Evidence map›Paper›PMID 37686717›Full record

ArticleNutrients2023

SLAB51 Multi-Strain Probiotic Formula Increases Oxygenation in Oxygen-Treated Preterm Infants.

Maria Elisabetta Baldassarre, Massimiliano Marazzato, Marta Pensa, Maria Teresa Loverro, Michele Quercia, Francesca Lombardi, Federico Schettini, Nicola Laforgia

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nutrients, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Maria Elisabetta BaldassarreSection of Neonatology and Neonatal Intensive Care Unit, Department of Interdisciplinary Medicine, "Aldo Moro" University of Bari, 70121 Bari, Italy.ORCID 0000-0003-0590-6664
Massimiliano MarazzatoDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Roma, Italy.
Marta PensaSection of Neonatology and Neonatal Intensive Care Unit, Department of Interdisciplinary Medicine, "Aldo Moro" University of Bari, 70121 Bari, Italy.
Maria Teresa LoverroSection of Neonatology and Neonatal Intensive Care Unit, Department of Interdisciplinary Medicine, "Aldo Moro" University of Bari, 70121 Bari, Italy.ORCID 0000-0003-3181-6443
Michele QuerciaSection of Neonatology and Neonatal Intensive Care Unit, Department of Interdisciplinary Medicine, "Aldo Moro" University of Bari, 70121 Bari, Italy.
Francesca LombardiDepartment of Life, Health & Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy.ORCID 0000-0002-0551-5076
Federico SchettiniNeonatology and Neonatal Intensive Care, SS. Annunziata Hospital, 80058 Taranto, Italy.ORCID 0000-0003-4976-6018
Nicola LaforgiaSection of Neonatology and Neonatal Intensive Care Unit, Department of Interdisciplinary Medicine, "Aldo Moro" University of Bari, 70121 Bari, Italy.ORCID 0000-0002-4610-1216
University of Bari Aldo Moro · ITOspedale SS. Annunziata · ITSapienza University of Rome · ITUniversity of L'Aquila · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Preterm infants are at risk of hypoxia and hyperoxia because of the immaturity of their respiratory and antioxidant systems, linked to increased morbidity and mortality. This study aimed to evaluate the efficacy of a single administration of the SLAB51 probiotic formula in improving oxygenation in respiratory distress syndrome (RDS)-affected premature babies, thus reducing their need for oxygen administration. Additionally, the capability of SLAB51 in activating the factor-erythroid 2-related factor (Nrf2) responsible for antioxidant responses was evaluated in vitro. In two groups of oxygen-treated preterm infants with similar SaO

Indexed as

HyperoxiaProbioticsAntioxidantsHumansInfantInfant, NewbornInfant, PrematureNF-E2-Related Factor 2OxygenAntioxidantsNF-E2-Related Factor 2Oxygenhyperoxiahypoxiaoxygenpreterm infantsprobioticsSLAB51

Identifiers

PMID37686717
PMCPMC10490200
OpenAlexW4386098919

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.